Recently, Redbiotec moved into the area of vaccine development by applying the unique expression technology to production of VLPs. To strengthen our position in this area, Dr. Sabine Wellnitz, formerly at Novartis and Roche, joined Redbiotec as a senior research scientist with a strong background in VLP production in insect cells.